πŸ‡ΊπŸ‡Έ FDA
Patent

US 7431942

Orally disintegrable tablets

granted A61KA61K31/4439A61K9/0056

Quick answer

US patent 7431942 (Orally disintegrable tablets) held by Takeda Pharmaceutical Company Limited expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4439, A61K9/0056, A61K9/1611, A61K9/1652